# Biomedical Data Scientist

#### Technical Skills: Python, MATLAB, R, SQL, AWS, Git, SPM, AFNI

---

## <ins>Education</ins>
B.A., Computational Cog. Sci. | Rice University (_May 2024_)

---

## <ins>Research</ins>
**National Cancer Institute (NCI/NIH) | (_June 2024 - Oct. 2024_)**<br />
*Radiation Oncology Branch*<br />
**Advisors: Andra V. Krauze, Erdal Tasci**

**Baylor College of Medicine | (_Jan. 2024 - May 2024_)**<br />
*Russel S. Ray Lab of Molecular Neurobiology*<br />
**Advisors: Russel S. Ray, Christopher Ward**

**Rice University School of Engineering | (_Aug. 2022 - May 2024_)**<br />
*Rice Data to Knowledge (D2K)*<br />
**Advisors: Bartlett D. Moore, Genevera Allen**

---

## <ins>Projects</ins>

### Navigating Omic Changes by Radiation Therapy in High-Grade Glioma/Glioblastoma - _National Cancer Institute_

Performed feature extraction, selection and engineering on multi-omic (proteomic, metabolomic) data from patients with pathology proven glioblastoma, a grade 4 brain tumor/glioma. This is in conjunction with research and development of AI models that can assist in revealing potential serum biomarkers, in addition to prediction of tumor characteristics (size, location, morphology, etc.) and patient outcomes. 

<img src="images/Figure 1 NCI.jpg?raw=true" />

The metabolomic data is first put into an RFE w/ K-Fold CV to find the most important features, which are then put into a deep-learning stacked autoencoder to compress the data. The compressed feature space is then put into another Random Forest to evaluate performance.

<img src="images/Figure 2 NCI.jpg?raw=true" />

Once the best parameters and architectures are found, the encoder is used to reconstruct only one target feature. The target feature can be a compound, giving us insights of which other compounds are most similar to the target.

<img src="images/Figure 3 NCI.jpg?raw=true" />

The result found 30+ novel metabolites that may show promise as biomarkers for glioma.

[![](https://img.shields.io/badge/Python-white?logo=Python)](#) [![](https://img.shields.io/badge/sklearn-white?logo=scikit-learn)](#) [![](https://img.shields.io/badge/Scikit%20Optimize-white?logo=data:image/png;base64,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)](#) [![](https://img.shields.io/badge/pandas-white?logo=data:image/png;base64,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)](#) [![](https://img.shields.io/badge/NumPy-white?logo=data:image/png;base64,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)](#)

<br><br>
<br><br>
<br><br>

### Identifying Cardio-Respiratory Signatures of SIDS in Mouse Models - _Baylor College of Medicine_

The underlying mechanisms of SIDS remain elusive due to its unpredictability on pre-mortem data. By leveraging a unique dataset derived from mouse pups simulating SIDS conditions, advanced signal processing techniques were combined with machine learning to analyze cardio-respiratory waveforms, given the hope of potential biomarker discovery.
<br><br>
Raw ECG data was extensively preprocessed to extract meaningful information (e.g., QRS complex morphology) to understand their relationship to SIDS.

<img src="images/QRS Detection Large.jpg?raw=true" />

![image](https://github.com/user-attachments/assets/4c14cb07-dc19-4afb-832b-72f039aa9362)

